...
首页> 外文期刊>Cancer chemotherapy and pharmacology. >Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors
【24h】

Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors

机译:高级实体肿瘤施用NLG207后纳米粒子结合和游离喜树碱的人口药代动力学分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose NLG207 (formerly CRLX101) is a nanoparticle-drug conjugate (NDC) of the potent topoisomerase I inhibitor, camptothecin (CPT). The present study sought to characterize the complex pharmacokinetics (PK) of NLG207 and better describe CPT release from nanoparticles using a population PK (popPK) model.
机译:目的NLG207(原名CRLX101)是一种有效的拓扑异构酶I抑制剂喜树碱(CPT)的纳米药物结合物(NDC)。本研究试图描述NLG207的复杂药代动力学(PK),并使用群体PK(popPK)模型更好地描述纳米颗粒释放的CPT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号